Autotranslated:

US Health Accelerator (2026)

Halcyon’s US Health Accelerator will serve US-based health ventures using technology to improve health outcomes, reduce barriers to care, and make healthcare more accessible and affordable. Through a hybrid programming format, selected entrepreneurs will attend a one-week, in-person residency in Chicago, Illinois, five virtual programming days, and a final one-week, in-person residency in Washington, DC.

• 🩺 Learn more about our Health vertical

• 👥 Meet our founders and ventures in the Health sector

Submit Your Eligibility Form to Apply

Eligibility

  • Location: Must be based in the US.
  • Stage: Must have a working Minimum Viable Product (MVP) and a realistic potential to scale. Applicants must demonstrate early user feedback or evidence of early commercial validation, such as pilots, LOIs, or revenue.
  • Team:
    • May apply with up to one Co-Founder.
    • Applicant must be the CEO or hold primary decision-making power.
    • Must be fluent in English (programming will be in English).
    • Must be at least 21 years of age by the start of the program.
  • Program Engagement: Applicant(s) must commit to participating in all residencies, program activities, events, and in-person and virtual sessions.
  • Impact: Must be developing a product and venture which contributes towards one or more of the UN’s 17 SDGs.

In addition, Halcyon scores each application based on four criteria: 1) Impact, 2) Scalability, 3) Innovation, and 4) Talent. For more on our eligibility criteria, visit our Applicants page.

Benefits

  • $10K in Amazon Web Services, Inc. (AWS) credits
  • $6K equity-free stipend per venture
  • Workshops with experts in product-market fit, capital strategy, and leadership
  • Professional advisors
  • Networking with investors and varied stakeholders in health
  • Access to Halcyon’s global community of 650+ founders
  • Continued benefits after your program—see our Alumni page for more

Sectors

We’re looking for ventures that address:

  • Health for women: solutions that address barriers and inequities experienced by women across the priority therapeutic areas (i.e., different symptom presentation, cultural barriers or cost issues). Solutions may serve women and men, but they must demonstrate how women benefit.
  • Underserved communities: solutions must improve access and affordability for populations that face economic, geographic or social barriers to care. The emphasis is on closing equity gaps rather than exclusively targeting low‑income individuals.

Solution types:

Ventures should clearly fit at least one of these solution categories and include a technology component:

  • Diagnostics: Point‑of‑care, remote, or AI‑enabled tools that make screening and disease monitoring more accessible.
  • Patient navigation & telehealth: Digital platforms that connect underserved patients with clinicians, streamline appointment scheduling, or provide remote care.
  • Financial inclusion & payment: Insurance innovations, payment mechanisms, or finance platforms that lower out‑of‑pocket costs and improve affordability.
  • Supply chain: Technologies that ensure the reliable distribution and availability of medicines, diagnostics, and supplies in underserved areas.
  • Physical health infrastructure: Novel clinic or diagnostic‑center models (i.e., mobile, modular) that bring care closer to underserved areas while incorporating a digital component for scale.
  • Other: Solutions addressing social determinants of health (SDOH) or community‑based delivery models that demonstrably improve access and affordability for underserved populations.

Solutions should tackle health challenges in priority areas including cancer, diabetes, cardiovascular disease, infectious diseases, vaccines and primary care. Ventures may be therapeutically specific or therapeutically agnostic if they improve access, quality, and continuity of care for these conditions.

Program Structure & Timeline

The final cohort is selected from 10 ventures across the US. The program is delivered in a hybrid modality through a virtual kickoff meeting, two one-week, in-person residencies in the US, and four additional virtual programming days.

Founders receive training in Halcyon’s methodology on product-market fit, capital strategy, and leadership, as well as access to critical resources and connections to accelerate their ventures.

Timeline:

  • April 13th, 2026: Application window opens
  • Mid-Late April, 2026: Last chance to submit your eligibility application to be considered for this application window! Halcyon team begins reviewing eligibility applications and sending out invitational applications
  • May 1st, 2026: Invitational application deadline
  • May 21st-22nd, 2026: Virtual pitch days for finalists
  • June 1st, 2026: Selected founders notified
  • June 24th, 2026: Virtual Program Kickoff
  • July 20th-24th, 2026: Residency Week #1 in Chicago, Illinois
  • August 19th, 2026: Virtual Meeting #2
  • September 2nd, 2026: Virtual Meeting #3
  • September 23rd, 2026: Virtual Meeting #4
  • October 15th, 2026: Virtual Meeting #5
  • November 2nd-6th: Residency #2 in Washington, DC

Ready to Apply?

It’s now easier than ever to apply to Halcyon with our eligibility form. Fill out this eligibility form before May 1st, 2026 to be considered for our 2026 US Health Accelerator. If your eligibility application meets our criteria and is a fit for the program, you’ll be invited to complete a second-round, invitational application.

Interested in Halcyon, but not the right fit for our US Health Accelerator? Submit your eligibility form today, and our team will contact you when a program opens that aligns with your venture.

Submit Your Eligibility Form